Evaluation of ultra low dose CT scans with Iomeron 400 contrast
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
This study is testing if using ultra low dose CT scans with a special contrast dye can help find lung problems like blood clots, cancer, and pneumonia while keeping radiation exposure low.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Trial ID | NCT06360627 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of ultra low dose computed tomography (CT) protocols combined with Iomeron 400 contrast for detecting pulmonary conditions such as lung embolism, lung cancer, and pneumonia. The approach aims to minimize radiation exposure while maintaining diagnostic accuracy. Participants will undergo CT scans specifically for pulmonary nodule detection and pneumonia follow-up. The study is designed to assess both the safety and efficacy of these imaging techniques.
Who should consider this trial
Good fit: Ideal candidates for this study are adults requiring CT scans for pulmonary nodule detection or pneumonia follow-up.
Not a fit: Patients under 18 years old or with a BMI over 30 may not benefit from this study due to the exclusion criteria.
Why it matters
Potential benefit: If successful, this study could lead to safer imaging protocols that reduce radiation exposure for patients while effectively diagnosing serious lung conditions.
How similar studies have performed: Other studies have shown promise in using low dose CT protocols, suggesting that this approach may be effective, though the specific combination with Iomeron 400 is less commonly tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * CT SCAN for pulmonary nodule detection/follow up * CT SCAN for pneumonia detection/follow up Exclusion Criteria: * under 18 * BMI over 30
Where this trial is running
Zurich
- University Hospital Zurich - Diagnostic Radiology — Zurich, Switzerland (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.